Results 291 to 300 of about 17,468,048 (391)
DEN Open, Volume 6, Issue 1, April 2026.Abstract Secondary aortoduodenal fistula (sADF) is a rare but life‐threatening complication after aortic graft surgery. Diagnosis is often challenging, particularly when contrast‐enhanced computed tomography (CT) and endoscopy results are inconclusive. We report a case in which diagnosis was challenging due to contrast media allergy and non‐diagnostic ...
Jun Kubota +6 more
wiley +1 more source
DEN Open, Volume 6, Issue 1, April 2026.ABSTRACT Aortoesophageal fistula (AEF) is a rare but life‐threatening condition. Initial management typically includes thoracic endovascular aortic repair (TEVAR) or aortic graft replacement to achieve hemostasis, followed by esophagectomy with aortic graft replacement and greater omentum wrapping to eliminate the source of infection.
Ryosuke Kawagoe +4 more
wiley +1 more source
DEN Open, Volume 6, Issue 1, April 2026.ABSTRACT Endoscopic submucosal dissection (ESD) is widely used for early esophageal cancer, even in patients with liver cirrhosis (LC). Corticosteroids, administered orally or by local injection, are often used to prevent post‐ESD esophageal stricture. However, their safety in patients with decompensated LC and refractory ascites remains unclear. A man
Yuki Tamura +9 more
wiley +1 more source
Genetic variants underlying precancerous conditions of hepatocellular carcinoma
International Journal of Cancer, Volume 158, Issue 3, Page 488-502, 1 February 2026.Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for 80% of cases worldwide. While chronic hepatitis B and C infections remain primary risk factors, emerging evidence highlights the increasing contributions of metabolic dysfunction‐associated steatotic liver disease (MASLD) and alcohol‐associated liver disease
Jonathan Jaime G. Guerrero +7 more
wiley +1 more source
Effects of immune checkpoint inhibitors on the pulmonary circulation in lung cancer patients
International Journal of Cancer, Volume 158, Issue 3, Page 682-696, 1 February 2026.What's new? Immune checkpoint inhibitors (ICIs) are effective against various cancers, but as more patients receive these therapies, more immune‐related adverse events (irAEs) emerge. Recent studies have suggested that ICIs are associated with an increase in pulmonary artery diameter and the ratio between pulmonary artery diameter and aortic diameter ...
Yao Xu +11 more
wiley +1 more source
American Journal of Hematology, Volume 101, Issue 1, Page 97-109, January 2026.ABSTRACT D‐dimer defines degradation products derived from the proteolysis mediated by plasmin on cross‐linked fibrin. The evidence‐based use of D‐dimer in some conditions has been consolidated. Currently, however, there is an entrenched prescription of D‐dimer testing to screen otherwise healthy subjects that may induce prescribing physicians to start
Armando Tripodi +11 more
wiley +1 more source
Hematological Oncology, Volume 44, Issue 1, January 2026.ABSTRACT Chimeric antigen receptor T (CAR‐T) cell therapies have revolutionized the treatment of hematological malignancies, achieving high response rates in patients with relapsed or refractory disease. Despite these benefits, CAR‐T cell therapies are associated with unique toxicities, including cytokine release syndrome (CRS), immune effector cell ...
Livia Donzelli +7 more
wiley +1 more source